The Children’s Tumor Foundation (CTF), the largest non-governmental funder of neurofibromatosis (NF) research, and PLOS ONE, a leading peer-reviewed scientific journal, are pleased to announce the successful completion of the first funding cycle of the Drug Discovery Initiative Registered Report (DDIRR) 2017 Awards, a funder-publisher partnership integrating the Registered Reports model into the grant application process.
Registered Reports pre-determine the research questions, methodology and design of a study to be carried out, and are designed to enhance the rigor, reproducibility and transparency of the science produced. CTF and PLOS ONE partnered together to review the 2017 DDIRR applications and granted three awards: Dr. Andrea McClatchey of Massachusetts General Hospital, Dr. Lei Xu of Massachusetts General Hospital, and Dr. Aaron Schindeler from the University of Sydney. The researchers also obtained an in-principle acceptance (IPA) to publication in the journal PLOS ONE. Provided the study is conducted according to plan, acceptance in principle is honored regardless of study outcome – thereby eliminating publication bias and maximizing the transparency of the funded work.
The reports are being placed on the Open Science Framework registered report portal (https://osf.io/rr/), where authors will have the opportunity to make public or embargo their reports until publication
Article originally posted at